{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:18:18Z","timestamp":1791919098926,"version":"4.3.4"},"reference-count":77,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T00:00:00Z","timestamp":1450656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0145333","type":"journal-article","created":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T13:41:55Z","timestamp":1450705315000},"page":"e0145333","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Reduced Levels of Proteasome Products in a Mouse Striatal Cell Model of Huntington\u2019s Disease"],"prefix":"10.1371","volume":"10","author":[{"given":"Sayani","family":"Dasgupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Mahallati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro M.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre K.","family":"Tashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emer S.","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd D.","family":"Fricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,12,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"CA Ross","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.tibs.2013.05.003","article-title":"Huntington's disease: underlying molecular mechanisms and emerging concepts","volume":"38","author":"J Labbadia","year":"2013","journal-title":"Trends Biochem Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"CA Ross","year":"2011","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.conb.2015.01.020","article-title":"Corticostriatal synaptic adaptations in Huntington's disease","volume":"33C","author":"JL Plotkin","year":"2015","journal-title":"Curr Opin Neurobiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1007\/s00018-007-7222-8","article-title":"Is the ubiquitin-proteasome system impaired in Huntington's disease?","volume":"64","author":"Z Ortega","year":"2007","journal-title":"Cell MolLife Sci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fnmol.2014.00077","article-title":"Ubiquitin-proteasome system involvement in Huntington's disease","volume":"7","author":"Z Ortega","year":"2014","journal-title":"Front Mol Neurosci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0896-6273(03)00606-8","article-title":"The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg","volume":"40","author":"A Ciechanover","year":"2003","journal-title":"Neuron"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nature02263","article-title":"Protein degradation and protection against misfolded or damaged proteins","volume":"426","author":"AL Goldberg","year":"2003","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1097-2765(04)00151-0","article-title":"Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins","volume":"14","author":"P Venkatraman","year":"2004","journal-title":"Mol Cell"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1091\/mbc.12.5.1393","article-title":"Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation","volume":"12","author":"S Waelter","year":"2001","journal-title":"Mol Biol Cell"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1038\/sj.emboj.7600426","article-title":"Inefficient degradation of truncated polyglutamine proteins by the proteasome","volume":"23","author":"CI Holmberg","year":"2004","journal-title":"EMBO J"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nature06022","article-title":"Global changes to the ubiquitin system in Huntington's disease","volume":"448","author":"EJ Bennett","year":"2007","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.nbd.2003.12.020","article-title":"Proteasome degrades soluble expanded polyglutamine completely and efficiently","volume":"16","author":"A Michalik","year":"2004","journal-title":"Neurobiol Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.molcel.2004.12.021","article-title":"Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation","volume":"17","author":"EJ Bennett","year":"2005","journal-title":"Mol Cell"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/j.1471-4159.2006.03968.x","article-title":"Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain","volume":"98","author":"M Diaz-Hernandez","year":"2006","journal-title":"J Neurochem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"11653","DOI":"10.1523\/JNEUROSCI.23-37-11653.2003","article-title":"Neuronal induction of the immunoproteasome in Huntington's disease","volume":"23","author":"M Diaz-Hernandez","year":"2003","journal-title":"J Neurosci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"13935","DOI":"10.1074\/jbc.M107706200","article-title":"Polyglutamine expansion, protein aggregation, proteasome activity, and neural survival","volume":"277","author":"Q Ding","year":"2002","journal-title":"J Biol Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/10.10.1049","article-title":"Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release","volume":"10","author":"NR Jana","year":"2001","journal-title":"Hum Mol Genet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.20207","article-title":"Generalized brain and skin proteasome inhibition in Huntington's disease","volume":"56","author":"H Seo","year":"2004","journal-title":"Ann Neurol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/jnr.21287","article-title":"Ubiquitin-proteasome system alterations in a striatal cell model of Huntington's disease","volume":"85","author":"JM Hunter","year":"2007","journal-title":"J Neurosci Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1083\/jcb.200709080","article-title":"Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice","volume":"180","author":"J Wang","year":"2008","journal-title":"J Cell Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"13986","DOI":"10.1073\/pnas.0906463106","article-title":"Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin\/proteasome system impairment","volume":"106","author":"CJ Maynard","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.febslet.2013.11.023","article-title":"Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies","volume":"588","author":"S Schipper-Krom","year":"2014","journal-title":"FEBS Lett"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"27068","DOI":"10.1074\/jbc.M113.486076","article-title":"Expanded polyglutamine-containing N-terminal huntingtin fragments are entirely degraded by mammalian proteasomes","volume":"288","author":"K Juenemann","year":"2013","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1083\/jcb.201110093","article-title":"Indirect inhibition of 26S proteasome activity in a cellular model of Huntington's disease","volume":"196","author":"MS Hipp","year":"2012","journal-title":"J Cell Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0076-6879(05)99033-2","article-title":"Application and analysis of the GFPu family of ubiquitin-proteasome system reporters","volume":"399","author":"NF Bence","year":"2005","journal-title":"Methods Enzymol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1471-4159.2006.03895.x","article-title":"Expanded polyglutamines impair synaptic transmission and ubiquitin-proteasome system in Caenorhabditis elegans","volume":"98","author":"LA Khan","year":"2006","journal-title":"J Neurochem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1074\/jbc.M806256200","article-title":"Misfolding of proteins with a polyglutamine expansion is facilitated by proteasomal chaperones","volume":"284","author":"E Rousseau","year":"2009","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"837015","DOI":"10.1155\/2012\/837015","article-title":"The ubiquitin-proteasome system in Huntington's Disease: Are proteasomes impaired, initiators of disease, or coming to the rescue?","volume":"2012","author":"S Schipper-Krom","year":"2012","journal-title":"Biochem Res Int"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.euprot.2014.02.009","article-title":"Intracellular peptides: From discovery to function","volume":"3","author":"ES Ferro","year":"2014","journal-title":"EuPA Open Proteomics"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1039\/c003317k","article-title":"Analysis of mouse brain peptides using mass spectrometry-based peptidomics: implications for novel functions ranging from non-classical neuropeptides to microproteins","volume":"6","author":"LD Fricker","year":"2010","journal-title":"Mol Biosyst"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1021\/pr100952f","article-title":"Peptidomic analysis of human cell lines","volume":"10","author":"JS Gelman","year":"2011","journal-title":"J Proteome Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e103604","DOI":"10.1371\/journal.pone.0103604","article-title":"Proteasome inhibitors alter levels of intracellular peptides in HEK293T and SH-SY5Y cells","volume":"9","author":"S Dasgupta","year":"2014","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e53263","DOI":"10.1371\/journal.pone.0053263","article-title":"Alterations of the intracellular peptidome in response to the proteasome inhibitor bortezomib","volume":"8","author":"JS Gelman","year":"2013","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1021\/pr2012076","article-title":"Peptidomic analysis of HEK293T cells: effect of the proteasome inhibitor epoxomicin on intracellular peptides","volume":"11","author":"LD Fricker","year":"2012","journal-title":"J Proteome Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","article-title":"Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells","volume":"9","author":"F Trettel","year":"2000","journal-title":"Hum Mol Genet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"9298","DOI":"10.1021\/ac801654h","article-title":"Multiple isotopic labels for quantitative mass spectrometry","volume":"80","author":"C Morano","year":"2008","journal-title":"Anal Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1021\/ac025614w","article-title":"Controlling deuterium isotope effects in comparative proteomics","volume":"74","author":"R Zhang","year":"2002","journal-title":"Anal Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/978-1-61779-458-2_31","article-title":"Quantitative peptidomics to measure neuropeptide levels in animal models relevant to psychiatric disorders","volume":"829","author":"JS Gelman","year":"2012","journal-title":"Methods Mol Biol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-1-61779-204-5_17","article-title":"Quantitative peptidomics of mice lacking Peptide-processing enzymes","volume":"768","author":"J Wardman","year":"2011","journal-title":"Methods Mol Biol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.euprot.2014.02.014","article-title":"Historical perspective of peptidomics","volume":"3","author":"M Schrader","year":"2014","journal-title":"EuPA Open Proteomics"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/mas.20079","article-title":"Peptidomics: Identification and quantification of endogenous peptides in neuroendocrine tissues","volume":"25","author":"LD Fricker","year":"2006","journal-title":"Mass Spectrom Rev"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1074-7613(02)00511-3","article-title":"Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I","volume":"18","author":"E Reits","year":"2003","journal-title":"Immunity"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1074-7613(04)00074-3","article-title":"A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation","volume":"20","author":"E Reits","year":"2004","journal-title":"Immunity"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1515\/BC.2006.191","article-title":"Leucine aminopeptidases: diversity in structure and function","volume":"387","author":"M Matsui","year":"2006","journal-title":"Biol Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1158\/0008-5472.CAN-06-0605","article-title":"Comparative selectivity and specificity of the proteasome inhibitors BzLLLCOCHO, PS-341, and MG-132","volume":"66","author":"LJ Crawford","year":"2006","journal-title":"Cancer Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"8582","DOI":"10.1074\/jbc.M509043200","article-title":"Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate","volume":"281","author":"AF Kisselev","year":"2006","journal-title":"J Biol Chem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-biochem-060410-150257","article-title":"Molecular architecture and assembly of the eukaryotic proteasome","volume":"82","author":"RJ Tomko Jr","year":"2013","journal-title":"Annu Rev Biochem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"33713","DOI":"10.1074\/jbc.R109.018481","article-title":"The 26 S proteasome: from basic mechanisms to drug targeting","volume":"284","author":"A Navon","year":"2009","journal-title":"J Biol Chem"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tibs.2013.10.004","article-title":"The unique functions of tissue-specific proteasomes","volume":"39","author":"A Kniepert","year":"2014","journal-title":"Trends Biochem Sci"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.abb.2012.04.018","article-title":"Differential roles of proteasome and immunoproteasome regulators Pa28 alpha beta, Pa28 gamma and Pa200 in the degradation of oxidized proteins","volume":"523","author":"AM Pickering","year":"2012","journal-title":"Arch Biochem Biophys"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/B978-0-12-397863-9.00006-7","article-title":"Degradation of damaged proteins: The main function of the 20S proteasome","volume":"109","author":"AM Pickering","year":"2012","journal-title":"Prog Mol Biol Transl Sci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molcel.2010.12.020","article-title":"Proteasome activators","volume":"41","author":"BM Stadtmueller","year":"2011","journal-title":"Mol Cell"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"C856","DOI":"10.1152\/ajpcell.1999.276.4.C856","article-title":"Effect of selective proteasome inhibitors on TNF-induced activation of primary and transformed endothelial cells","volume":"276","author":"TJ Kalogeris","year":"1999","journal-title":"Am J Physiol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0076-6879(99)00140-8","article-title":"Inhibition of NF-kappa B activation in vitro and in vivo: role of 26S proteasome","volume":"300","author":"MB Grisham","year":"1999","journal-title":"Methods Enzymol"},{"key":"ref56","first-page":"1419","article-title":"Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma","volume":"7","author":"JB Sunwoo","year":"2001","journal-title":"Clin Cancer Res"},{"key":"ref57","first-page":"3535","article-title":"Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition","volume":"61","author":"JC Cusack Jr","year":"2001","journal-title":"Cancer Res"},{"key":"ref58","first-page":"3071","article-title":"The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells","volume":"61","author":"T Hideshima","year":"2001","journal-title":"Cancer Res"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1074\/mcp.M112.026013","article-title":"The effect of proteasome inhibition on the generation of the human leukocyte antigen (HLA) peptidome","volume":"12","author":"E Milner","year":"2013","journal-title":"Mol Cell Proteomics"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1158\/1078-0432.CCR-10-1950","article-title":"Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverse events","volume":"17","author":"S Arastu-Kapur","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref61","article-title":"Delayed cell cycle progression in STHdh\/Hdh cells, a cell model for Huntington's disease mediated by microRNA-19a, microRNA-146a and microRNA-432","author":"E Das","year":"2015","journal-title":"Microrna"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.bbrc.2015.02.137","article-title":"Micro RNA-214 contributes to proteasome independent downregulation of beta catenin in Huntington's disease knock-in striatal cell model STHdhQ111\/Q111","volume":"459","author":"S Ghatak","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1750-1326-8-45","article-title":"Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease","volume":"8","author":"RA Quintanilla","year":"2013","journal-title":"Mol Neurodegener"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.7618107","article-title":"Inactivation of the mouse Huntington's disease gene homolog Hdh","volume":"269","author":"MP Duyao","year":"1995","journal-title":"Science"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1212\/WNL.0b013e318249f683","article-title":"CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion","volume":"78","author":"JM Lee","year":"2012","journal-title":"Neurology"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"16711","DOI":"10.1074\/jbc.M113.537118","article-title":"A novel intracellular peptide derived from G1\/S cyclin D2 induces cell death","volume":"289","author":"CB de Araujo","year":"2014","journal-title":"J Biol Chem"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1002\/pmic.201200032","article-title":"Natural intracellular peptides can modulate the interactions of mouse brain proteins and thimet oligopeptidase with 14-3-3 epsilon and calmodulin","volume":"12","author":"LC Russo","year":"2012","journal-title":"Proteomics"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"24448","DOI":"10.1074\/jbc.M801252200","article-title":"Intracellular peptides as natural regulators of cell signaling","volume":"283","author":"FM Cunha","year":"2008","journal-title":"J Biol Chem"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.molcel.2010.01.015","article-title":"The matrix peptide exporter HAF-1 signals a mitochondrial UPR by activating the transcription factor ZC376.7 in C. elegans","volume":"37","author":"CM Haynes","year":"2010","journal-title":"Mol Cell"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1126\/science.1188158","article-title":"Small peptides switch the transcriptional activity of Shavenbaby during Drosophila embryogenesis","volume":"329","author":"T Kondo","year":"2010","journal-title":"Science"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/1389203053545462","article-title":"Design and structure of peptide and peptidomimetic antagonists of protein-protein interaction","volume":"6","author":"LO Sillerud","year":"2005","journal-title":"Curr Protein Pept Sci"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/bip.21164","article-title":"Peptidic modulators of protein-protein interactions: progress and challenges in computational design","volume":"91","author":"M Rubinstein","year":"2009","journal-title":"Biopolymers"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tem.2008.10.002","article-title":"Rationally designed peptide regulators of protein kinase C","volume":"20","author":"EN Churchill","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.cbpa.2009.05.125","article-title":"The road less traveled: modulating signal transduction enzymes by inhibiting their protein-protein interactions","volume":"13","author":"MR Arkin","year":"2009","journal-title":"Curr Opin Chem Biol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"320","DOI":"10.4161\/bioe.21272","article-title":"Increasing the range of drug targets: interacting peptides provide leads for the development of oncoprotein inhibitors","volume":"3","author":"B Groner","year":"2012","journal-title":"Bioengineered"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.sbi.2013.07.006","article-title":"Peptide docking and structure-based characterization of peptide binding: from knowledge to know-how","volume":"23","author":"N London","year":"2013","journal-title":"Curr Opin Struct Biol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"25460","DOI":"10.1074\/jbc.R114.583906","article-title":"Harnessing the unique structural properties of isolated alpha-helices","volume":"289","author":"CJ Swanson","year":"2014","journal-title":"J Biol Chem"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0145333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T16:05:35Z","timestamp":1567440335000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0145333"}},"subtitle":[],"editor":[{"given":"Yoshitaka","family":"Nagai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,21]]},"references-count":77,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0145333","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,21]]}}}